Loading stock data…
$13.79-0.68 (-4.70%)
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions.
Carlsmed, Inc. in the Healthcare sector is trading at $13.79 with a market capitalization of $426M. Wall Street consensus targets $19.40 (5 analysts), implying a +40.7% move over the next 12 months. The stock is currently 20% below its 52-week high of $17.23, remaining 12.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $18.94M↑ | $16.12M↑ | $15.16M↑ | $13.07M↑ | $12.08M |
| Gross Profit | $14.54M↑ | $12.43M↑ | $11.61M↑ | $9.93M↑ | $8.87M |
| Operating Income | -$11.04M↓ | -$9.28M↑ | -$9.32M↓ | -$9.04M↓ | -$6.50M |
| Net Income | -$10.51M↓ | -$8.70M↓ | -$8.61M↓ | -$8.53M↓ | -$6.77M |
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. I...